Quinolone Activity against Anaerobes
- 1 January 1995
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 49 (Supplement) , 76-80
- https://doi.org/10.2165/00003495-199500492-00012
Abstract
Currently available quinolones are either inactive or marginally active against anaerobic bacteria. This review summarises the in vitro activity of currently available as well as experimental quinolones against clinically significant anaerobic bacteria. Quinolones with low activity against anaerobes include ciprofloxacin, ofloxacin, levofloxacin, fleroxacin, pefloxacin, enoxacin, lomefloxacin and probably E 4868 and NM 441. Compounds with intermediate anaerobe activity include sparfloxacin, grepafloxacin, PD 131628 and AM 1155. Quinolones that are very active against anaerobes include clinafloxacin and DU 6859a. CP 99 219, a naphthyridone, is also very active against anaerobes. Toxicity problems have necessitated the withdrawal of some quinolones shown to have intermediate activity (temafloxacin and tosufloxacin) and the discontinuation of the development of some investigational agents (Win 57273 and BAY Y 3118) with high activity. Conclusions regarding the therapeutic value of quinolones against human anaerobic infections await further clinical toxicological and pharmacokinetic studies.Keywords
This publication has 32 references indexed in Scilit:
- Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacinJournal of Antimicrobial Chemotherapy, 1993
- Antibacterial activity of NM394, the active form of prodrug NM441, a new quinoloneAntimicrobial Agents and Chemotherapy, 1993
- Susceptibility of anaerobic bacteria isolated from intra-abdominal infections to ofloxacin and interaction of ofloxacin with metronidazoleAntimicrobial Agents and Chemotherapy, 1991
- Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditionsJournal of Antimicrobial Chemotherapy, 1991
- In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacinAntimicrobial Agents and Chemotherapy, 1991
- In-vitro activity of temafloxacin against anaerobic bacteria: a comparative studyJournal of Antimicrobial Chemotherapy, 1991
- β-Lactamase production, β-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centresJournal of Antimicrobial Chemotherapy, 1990
- Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centersAntimicrobial Agents and Chemotherapy, 1990
- In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agentsAntimicrobial Agents and Chemotherapy, 1989
- Reduction of oral flora with ciprofloxacin in healthy volunteersJournal of Antimicrobial Chemotherapy, 1988